Background With the rebound of coronavirus disease 2019(COVID19)epidemic in some countries with high vaccination rate,many concerns on vaccine efcacy have emerged.For example,are the current vaccines inefective agains...Background With the rebound of coronavirus disease 2019(COVID19)epidemic in some countries with high vaccination rate,many concerns on vaccine efcacy have emerged.For example,are the current vaccines inefective against severe acute respiratory syndrome coronavirus 2(SARSCOV-2)variants?What’s the status of breakthrough infection?To what extent are non-pharmacological interventions(NPIs)lifted after high vaccination rate?To clarify these questions,we summarized important fndings based on literature and Chinese experience.展开更多
基金Chinese Postdoctoral Science Foundation(2020T130020ZX)Guangzhou Sci‑ence and Technology Project(202102021285).
文摘Background With the rebound of coronavirus disease 2019(COVID19)epidemic in some countries with high vaccination rate,many concerns on vaccine efcacy have emerged.For example,are the current vaccines inefective against severe acute respiratory syndrome coronavirus 2(SARSCOV-2)variants?What’s the status of breakthrough infection?To what extent are non-pharmacological interventions(NPIs)lifted after high vaccination rate?To clarify these questions,we summarized important fndings based on literature and Chinese experience.
